GDUFA III: Excipients Group Seeks Seat At Negotiating Table, But US FDA Skeptical

A realistic literal depiction of the saying get a foot in the door - 3D render
IPEC-Americas is trying to get a foot in the door to industry's negotiations with the FDA on GDUFA III. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics